Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $3.78B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Arcus Biosciences, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 131
- +2 vs. Q2 2021
- Shares held
- 48.3M
- +3.12M (+6.9%) vs. Q2 2021
- Total value
- $1.68B
- +$443.9M (+35.8%) vs. Q2 2021
- New holders
- 17
- 36 more added
- Sold out
- 15
- 51 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RCUS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 231 | $3.78B |
| Q1 2026 | 211 | $2.57B |
| Q4 2025 | 209 | $2.89B |
| Q3 2025 | 190 | $1.37B |
| Q2 2025 | 186 | $811.5M |
| Q1 2025 | 187 | $763.3M |
| Q4 2024 | 186 | $1.25B |
| Q3 2024 | 187 | $815.7M |
| Q2 2024 | 193 | $790.9M |
| Q1 2024 | 172 | $997.7M |
| Q4 2023 | 185 | $1.01B |
| Q3 2023 | 187 | $947.9M |
| Q2 2023 | 181 | $1.11B |
| Q1 2023 | 180 | $1.01B |
| Q4 2022 | 200 | $1.11B |
| Q3 2022 | 183 | $1.37B |
| Q2 2022 | 173 | $1.33B |
| Q1 2022 | 157 | $1.60B |
| Q4 2021 | 142 | $2.06B |
| Q3 2021 | 131 | $1.68B |
| Q2 2021 | 130 | $1.24B |
| Q1 2021 | 148 | $1.25B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Arcus Biosciences, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of New York Mellon Corp | 220,393 | $7.68M | 0.00% | +16,982+8.3% | Added |
| Invesco Ltd. | 224,684 | $7.83M | 0.00% | +6,331+2.9% | Added |
| Parkman Healthcare Partners LLC | 236,637 | $8.25M | 2.09% | −10,000−4.1% | Reduced |
| JPMorgan Chase & Co | 269,359 | $9.39M | 0.00% | −4,374−1.6% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 272,607 | $9.51M | 0.05% | +3,896+1.4% | Added |
| Nuveen Asset Management, LLC | 278,043 | $10.1M | 0.00% | −147,031−34.6% | Reduced |
| Gilder Gagnon Howe & Co LLC | 291,003 | $10.1M | 0.05% | −6,085−2.0% | Reduced |
| Two Sigma Advisers, LP | 291,300 | $10.2M | 0.03% | −85,200−22.6% | Reduced |
| Ameriprise Financial Inc | 298,410 | $10.4M | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 355,241 | $12.4M | 0.00% | +10,682+3.1% | Added |
| Bain Capital Public Equity Management II, LLC | 454,863 | $15.9M | 0.65% | +454,863 | New |
| Macquarie Group Ltd | 461,980 | $16.1M | 0.01% | −1,418−0.3% | Reduced |
| Northern Trust Corp | 640,232 | $22.3M | 0.00% | −27,949−4.2% | Reduced |
| TimesSquare Capital Management, LLC | 652,240 | $22.7M | 0.20% | −35,300−5.1% | Reduced |
| Sectoral Asset Management Inc | 739,010 | $25.8M | 2.14% | +64,750+9.6% | Added |
| Geode Capital Management, LLC | 783,176 | $27.3M | 0.00% | +11,622+1.5% | Added |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 785,106 | $27.4M | 0.10% | +473,310+151.8% | Added |
| Octagon Capital Advisors LP | 970,164 | $33.8M | 8.33% | +210,000+27.6% | Added |
| Franklin Resources Inc | 1,457,349 | $50.8M | 0.02% | +581,311+66.4% | Added |
| Pictet Asset Management SA | 1,501,228 | $52.3M | 0.06% | +1,501,228 | New |
| Woodline Partners LP | 1,699,113 | $59.2M | 0.98% | +35,545+2.1% | Added |
| Invus Financial Advisors, LLC | 1,842,077 | $64.2M | 17.21% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,084,883 | $72.7M | 2.54% | 00.0% | Unchanged |
| State Street Corp | 2,331,630 | $81.3M | 0.00% | −354,071−13.2% | Reduced |
| Vanguard Group Inc | 2,466,479 | $86.0M | 0.00% | +370.0% | Added |
| FMR LLC | 3,091,165 | $107.8M | 0.01% | 00.0% | Unchanged |
| BVF Inc | 3,229,822 | $112.6M | 4.39% | +432,000+15.4% | Added |
| PFM Health Sciences, LP | 3,431,010 | $119.6M | 3.88% | −67,250−1.9% | Reduced |
| Alphabet Inc. | 4,100,475 | $143.0M | 3.39% | −513,343−11.1% | Reduced |
| BlackRock Inc. | 4,202,960 | $146.6M | 0.00% | +164,232+4.1% | Added |
| EcoR1 Capital, LLC | 5,122,359 | $178.6M | 6.31% | +1,787,112+53.6% | Added |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −275,700−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −86,438−100.0% | Sold out |
| FIL Ltd | 0 | $0 | 0.00% | −36,441−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −33,479−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −10,540−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −10,400−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −10,085−100.0% | Sold out |
| Credit Agricole S A | 0 | $0 | 0.00% | −6,200−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −5,022−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −4,874−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −3,102−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Wexford Capital LP | – | – | – | – | Not filed |